Invention Grant
- Patent Title: Treatment of diabetes mellitus by long-acting formulations of insulins
-
Application No.: US16700541Application Date: 2019-12-02
-
Publication No.: US11191722B2Publication Date: 2021-12-07
- Inventor: Isabel Muhlen-Bartmer , Monika Ziemen
- Applicant: SANOFI
- Applicant Address: FR Paris
- Assignee: SANOFI
- Current Assignee: SANOFI
- Current Assignee Address: FR Paris
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: EP13305432 20130403,EP13290188 20130808,EP13306412 20131015
- Main IPC: A61K9/08
- IPC: A61K9/08 ; A61K38/28 ; A61K9/00 ; A61P3/10 ; A61K31/155 ; A61K38/26 ; A61K47/02 ; A61K47/10 ; A61K47/26
Abstract:
The application relates to an aqueous pharmaceutical formulation for use in the treatment of Type I or Type II Diabetes Mellitus, wherein the treatment reduces the risk of nocturnal hypoglycemia, said formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine.
Public/Granted literature
- US20200170945A1 Treatment of Diabetes Mellitus by Long-Acting Formulations of Insulins Public/Granted day:2020-06-04
Information query
